GleamWall
中文EN

TNGX Tango Therapeutics, Inc.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1819133 · Fiscal year ends 12/31

Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY121.5%
TTM net income YoY15.0%
TTM EPS YoY36.4%
Revenue 3-yr CAGR16.9%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-253.4%
Net margin-229.9%
FCF margin-268.1%
EBITDA margin-249.8%

Returns

ROE-21.3%
ROA-18.9%
ROIC (approx.)-28.5%
Asset turnover0.08x

Leverage & solvency

Liabilities / assets4.6%
Debt / equity0.00x
Current ratio50.82x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.16x
Accruals ratio3.1%
Payout ratio—
Capex / revenue0.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$62.38M$42.07M
R&D expense$132.16M$143.92M
SG&A expense$41.51M$43.75M
Operating income-$111.29M-$145.59M
Pretax income-$101.59M-$130.09M
Income tax$4,000$208,000
Net income-$101.59M-$130.30M
EBITDA-$109.01M-$143.10M
EPS (basic)-0.87-1.19
EPS (diluted)-0.87-1.19
Weighted avg. shares (diluted)116.17M109.23M
Banking
Net interest income$5.63M$7.89M
Balance sheet
Cash & equivalents$112.28M$69.53M
Short-term investments$230.86M$188.39M
Current assets$353.76M$266.34M
PP&E, net$6.87M$8.10M
Total assets$398.69M$316.49M
Current liabilities$21.68M$38.17M
Total liabilities$52.51M$116.97M
Shareholders' equity$346.18M$199.52M
Shares outstanding135.94M107.73M
Cash flow statement
Operating cash flow-$138.89M-$131.50M
Capital expenditure$1.05M$754,000
Free cash flow-$139.93M-$132.25M
Investing cash flow-$40.87M$86.13M
Financing cash flow$222.50M$47.66M
Depreciation & amortization$2.28M$2.50M
Stock-based compensation$26.43M$28.90M

Free plan shows the latest 2 periods; Pro shows all 6 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.